{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T03:47:26Z","timestamp":1789444046544,"version":"build-2803163510"},"reference-count":49,"publisher":"Japan Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2022]]},"DOI":"10.1507\/endocrj.ej20-0695","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T22:08:52Z","timestamp":1644444532000},"page":"613-625","source":"Crossref","is-referenced-by-count":5,"title":["Human umbilical cord mesenchymal stem cells alleviate the imbalance of CD4&lt;sup&gt;+&lt;\/sup&gt; T cells &lt;i&gt;via&lt;\/i&gt; protein tyrosine phosphatase non-receptor type 2\/signal transducer and activator of transcription 3 signaling in ameliorating experimental autoimmune thyroiditis in rats"],"prefix":"10.1507","volume":"69","author":[{"given":"Junjie","family":"Gao","sequence":"first","affiliation":[{"name":"Medical College, Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxia","family":"Hu","sequence":"additional","affiliation":[{"name":"The Laboratory of Thyroid Disease, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kui","family":"Che","sequence":"additional","affiliation":[{"name":"The Laboratory of Thyroid Disease, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengli","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Affiliated Hospital of Qingdao University, Qingdao, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Ramos-Levi AM, Marazuela M (2016) Pathogenesis of thyroid autoimmune disease: the role of cellular mechanisms. Endocrinol Nutr 63: 421\u2013429.","DOI":"10.1016\/j.endonu.2016.04.003"},{"key":"2","unstructured":"2 Mincer DL, Jialal I (2021) Hashimoto Thyroiditis. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island, Florida, USA."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Pyzik A, Grywalska E, Matyjaszek-Matuszek B, Rolinski J (2015) Immune disorders in Hashimoto\u2019s thyroiditis: what do we know so far? J Immunol Res 2015: 979167.","DOI":"10.1155\/2015\/979167"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Rydzewska M, Jaromin M, Pasierowska IE, Stozek K, Bossowski A (2018) Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid Res 11: 2.","DOI":"10.1186\/s13044-018-0046-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Yasuda K, Takeuchi Y, Hirota K (2019) The pathogenicity of Th17 cells in autoimmune diseases. Semin Immunopathol 41: 283\u2013297.","DOI":"10.1007\/s00281-019-00733-8"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Drugarin D, Negru S, Koreck A, Zosin I, Cristea C (2000) The pattern of a TH1 cytokine in autoimmune thyroiditis. Immunol Lett 71: 73\u201377.","DOI":"10.1016\/S0165-2478(99)00156-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Nepom GT, St Clair EW, Turka LA (2011) Challenges in the pursuit of immune tolerance. Immunol Rev 241: 49\u201362.","DOI":"10.1111\/j.1600-065X.2011.01003.x"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Goschl L, Scheinecker C, Bonelli M (2019) Treg cells in autoimmunity: from identification to Treg-based therapies. Semin Immunopathol 41: 301\u2013314.","DOI":"10.1007\/s00281-019-00741-8"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9 Jin X, Wang S, Zhao X, Jin Q, Fan C, et al. (2016) Coumestrol inhibits autoantibody production through modulating Th1 response in experimental autoimmune thyroiditis. Oncotarget 7: 52797\u201352809.","DOI":"10.18632\/oncotarget.10353"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10 Vitales-Noyola M, Ramos-Levi AM, Martinez-Hernandez R, Serrano-Somavilla A, Sampedro-Nunez M, et al. (2017) Pathogenic Th17 and Th22 cells are increased in patients with autoimmune thyroid disorders. Endocrine 57: 409\u2013417.","DOI":"10.1007\/s12020-017-1361-y"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Xue H, Yu X, Ma L, Song S, Li Y, et al. (2015) The possible role of CD4<sup>+<\/sup>CD25<sup>high<\/sup>Foxp3<sup>+<\/sup>\/CD4<sup>+<\/sup>IL-17A<sup>+<\/sup> cell imbalance in the autoimmunity of patients with Hashimoto thyroiditis. Endocrine 50: 665\u2013673.","DOI":"10.1007\/s12020-015-0569-y"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Zhang K, Wang Y, Ma W, Hu Z, Zhao P (2017) Genistein improves thyroid function in Hashimoto\u2019s thyroiditis patients through regulating Th1 cytokines. Immunobiology 222: 183\u2013187.","DOI":"10.1016\/j.imbio.2016.10.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Shao S, Yu X, Shen L (2018) Autoimmune thyroid diseases and Th17\/Treg lymphocytes. Life Sci 192: 160\u2013165.","DOI":"10.1016\/j.lfs.2017.11.026"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Doody KM, Bourdeau A, Tremblay ML (2009) T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease. Immunol Rev 228: 325\u2013341.","DOI":"10.1111\/j.1600-065X.2008.00743.x"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Spalinger MR, Kasper S, Chassard C, Raselli T, Frey-Wagner I, et al. (2015) PTPN2 controls differentiation of CD4<sup>+<\/sup> T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol 8: 918\u2013929.","DOI":"10.1038\/mi.2014.122"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Wiede F, La Gruta NL, Tiganis T (2014) PTPN2 attenuates T-cell lymphopenia-induced proliferation. Nat Commun 5: 3073.","DOI":"10.1038\/ncomms4073"},{"key":"17","doi-asserted-by":"publisher","unstructured":"17 Khor B, Gardet A, Xavier RJ (2011) Genetics and pathogenesis of inflammatory bowel disease. Nature 474: 307\u2013317.","DOI":"10.1038\/nature10209"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Pike KA, Tremblay ML (2018) Protein tyrosine phosphatases: regulators of CD4 T cells in inflammatory bowel disease. Front Immunol 9: 2504.","DOI":"10.3389\/fimmu.2018.02504"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Wiede F, Brodnicki TC, Goh PK, Leong YA, Jones GW, et al. (2019) T-cell-specific PTPN2 deficiency in NOD mice accelerates the development of type 1 diabetes and autoimmune comorbidities. Diabetes 68: 1251\u20131266.","DOI":"10.2337\/db18-1362"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Zhu Y, Yao J, Duan Y, Xu H, Cheng Q, et al. (2020) Protein expression profile in rat silicosis model reveals upregulation of PTPN2 and its inhibitory effect on epithelial-mesenchymal transition by dephosphorylation of STAT3. Int J Mol Sci 21: 1189.","DOI":"10.3390\/ijms21041189"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kim M, Morales LD, Jang IS, Cho YY, Kim DJ (2018) Protein tyrosine phosphatases as potential regulators of STAT3 signaling. Int J Mol Sci 19: 2708.","DOI":"10.3390\/ijms19092708"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Li Y, Zhou H, Wang F, Han L, Liu M, et al. (2018) Overexpression of PTPN2 in visceral adipose tissue ameliorated atherosclerosis <i>via<\/i> T cells polarization shift in diabetic apoe\u2013\/\u2013 mice. Cell Physiol Biochem 46: 118\u2013132.","DOI":"10.1159\/000488415"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Wu R, He Q, Chen H, Xu M, Zhao N, et al. (2017) MicroRNA-448 promotes multiple sclerosis development through induction of Th17 response through targeting protein tyrosine phosphatase non-receptor type 2 (PTPN2). Biochem Biophys Res Commun 486: 759\u2013766.","DOI":"10.1016\/j.bbrc.2017.03.115"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Purvis HA, Anderson AE, Young DA, Isaacs JD, Hilkens CM (2014) A negative feedback loop mediated by STAT3 limits human Th17 responses. J Immunol 193: 1142\u20131150.","DOI":"10.4049\/jimmunol.1302467"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Durant L, Watford WT, Ramos HL, Laurence A, Vahedi G, et al. (2010) Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis. Immunity 32: 605\u2013615.","DOI":"10.1016\/j.immuni.2010.05.003"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Gharibi T, Babaloo Z, Hosseini A, Abdollahpour-Alitappeh M, Hashemi V, et al. (2020) Targeting STAT3 in cancer and autoimmune diseases. Eur J Pharmacol 878: 173107.","DOI":"10.1016\/j.ejphar.2020.173107"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Uccelli A, de Rosbo NK (2015) The immunomodulatory function of mesenchymal stem cells: mode of action and pathways. Ann N Y Acad Sci 1351: 114\u2013126.","DOI":"10.1111\/nyas.12815"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Li H, Shen S, Fu H, Wang Z, Li X, et al. (2019) Immunomodulatory functions of mesenchymal stem cells in tissue engineering. Stem Cells Int 2019: 9671206.","DOI":"10.1155\/2019\/9671206"},{"key":"29","doi-asserted-by":"publisher","unstructured":"29 von Bahr V, Millar JE, Malfertheiner MV, Ki KK, Passmore MR, et al. (2019) Mesenchymal stem cells may ameliorate inflammation in an <i>ex vivo<\/i> model of extracorporeal membrane oxygenation. Perfusion 34: 15\u201321.","DOI":"10.1177\/0267659118787432"},{"key":"30","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4236\/scd.2013.33020","volume":"3","author":"S Takikawa","year":"2013","unstructured":"30 Takikawa S, Yamamoto A, Sakai K, Shohara R, Iwase A, et al. (2013) Human umbilical cord-derived mesenchymal stromal cells promote sensory recovery in a spinal cord injury rat model. Stem Cell Discovery 3: 155\u2013163.","journal-title":"Stem Cell Discovery","ISSN":"https:\/\/id.crossref.org\/issn\/2161-6760","issn-type":"print"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Abbaspanah B, Momeni M, Ebrahimi M, Mousavi SH (2018) Advances in perinatal stem cells research: a precious cell source for clinical applications. Regen Med 13: 595\u2013610.","DOI":"10.2217\/rme-2018-0019"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Hu J, Wang F, Sun R, Wang Z, Yu X, et al. (2014) Effect of combined therapy of human Wharton\u2019s jelly-derived mesenchymal stem cells from umbilical cord with sitagliptin in type 2 diabetic rats. Endocrine 45: 279\u2013287.","DOI":"10.1007\/s12020-013-9984-0"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Wang D, Niu L, Feng X, Yuan X, Zhao S, et al. (2017) Long-term safety of umbilical cord mesenchymal stem cells transplantation for systemic lupus erythematosus: a 6-year follow-up study. Clin Exp Med 17: 333\u2013340.","DOI":"10.1007\/s10238-016-0427-0"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Ma D, Xu K, Zhang G, Liu Y, Gao J, et al. (2019) Immunomodulatory effect of human umbilical cord mesenchymal stem cells on T lymphocytes in rheumatoid arthritis. Int Immunopharmacol 74: 105687.","DOI":"10.1016\/j.intimp.2019.105687"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Nugroho WS, Kusindarta DL, Susetya H, Fitriana I, Mulyani GT, et al. (2016) The structural and functional recovery of pancreatic beta-cells in type 1 diabetes mellitus induced mesenchymal stem cell-conditioned medium. Vet World 9: 535\u2013539.","DOI":"10.14202\/vetworld.2016.535-539"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Zhang J, Lv S, Liu X, Song B, Shi L (2018) Umbilical cord mesenchymal stem cell treatment for Crohn\u2019s disease: a randomized controlled clinical trial. Gut Liver 12: 73\u201378.","DOI":"10.5009\/gnl17035"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Calcaterra V, Nappi RE, Regalbuto C, De Silvestri A, Incardona A, et al. (2020) Gender differences at the onset of autoimmune thyroid diseases in children and adolescents. Front Endocrinol (Lausanne) 11: 229.","DOI":"10.3389\/fendo.2020.00229"},{"key":"38","doi-asserted-by":"publisher","unstructured":"38 Hu J, Wang Y, Wang F, Wang L, Yu X, et al. (2015) Effect and mechanisms of human Wharton\u2019s jelly-derived mesenchymal stem cells on type 1 diabetes in NOD model. Endocrine 48: 124\u2013134.","DOI":"10.1007\/s12020-014-0219-9"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39 Maleki M, Ghanbarvand F, Reza Behvarz M, Ejtemaei M, Ghadirkhomi E (2014) Comparison of mesenchymal stem cell markers in multiple human adult stem cells. Int J Stem Cells 7: 118\u2013126.","DOI":"10.15283\/ijsc.2014.7.2.118"},{"key":"40","unstructured":"40 Li H, Min J, Mao X, Wang X, Yang Y, et al. (2018) Edaravone ameliorates experimental autoimmune thyroiditis in rats through HO-1-dependent STAT3\/PI3K\/Akt pathway. Am J Transl Res 10: 2037\u20132046."},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Wang Z, Wei Q, Wang H, Han L, Dai H, et al. (2020) Mesenchymal stem cell therapy using human umbilical cord in a rat model of autoimmune-induced premature ovarian failure. Stem Cells Int 2020: 3249495.","DOI":"10.1155\/2020\/3249495"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Liu H, Tian Q, Ai X, Qin Y, Cui Z, et al. (2017) Dihydroartemisinin attenuates autoimmune thyroiditis by inhibiting the CXCR3\/PI3K\/AKT\/NF-kappaB signaling pathway. Oncotarget 8: 115028\u2013115040.","DOI":"10.18632\/oncotarget.22854"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Beliakova-Bethell N, Hezareh M, Wong JK, Strain MC, Lewinski MK, et al. (2017) Relative efficacy of T cell stimuli as inducers of productive HIV-1 replication in latently infected CD4 lymphocytes from patients on suppressive cART. Virology 508: 127\u2013133.","DOI":"10.1016\/j.virol.2017.05.008"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44 Wang M, Yuan Q, Xie L (2018) Mesenchymal stem cell-based immunomodulation: properties and clinical application. Stem Cells Int 2018: 3057624.","DOI":"10.1155\/2018\/3057624"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45 van den Akker F, Vrijsen KR, Deddens JC, Buikema JW, Mokry M, et al. (2018) Suppression of T cells by mesenchymal and cardiac progenitor cells is partly mediated <i>via<\/i> extracellular vesicles. Heliyon 4: e00642.","DOI":"10.1016\/j.heliyon.2018.e00642"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46 Wiede F, Shields BJ, Chew SH, Kyparissoudis K, van Vliet C, et al. (2011) T cell protein tyrosine phosphatase attenuates T cell signaling to maintain tolerance in mice. J Clin Invest 121: 4758\u20134774.","DOI":"10.1172\/JCI59492"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47 Egwuagu CE (2009) STAT3 in CD4+ T helper cell differentiation and inflammatory diseases. Cytokine 47: 149\u2013156.","DOI":"10.1016\/j.cyto.2009.07.003"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48 Lee H, Pal SK, Reckamp K, Figlin RA, Yu H (2011) STAT3: a target to enhance antitumor immune response. Curr Top Microbiol Immunol 344: 41\u201359.","DOI":"10.1007\/82_2010_51"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49 Priceman SJ, Kujawski M, Shen S, Cherryholmes GA, Lee H, et al. (2013) Regulation of adipose tissue T cell subsets by Stat3 is crucial for diet-induced obesity and insulin resistance. Proc Natl Acad Sci U S A 110: 13079\u201313084.","DOI":"10.1073\/pnas.1311557110"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/6\/69_EJ20-0695\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,2]],"date-time":"2022-07-02T03:26:23Z","timestamp":1656732383000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/69\/6\/69_EJ20-0695\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":49,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej20-0695","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022]]},"article-number":"EJ20-0695"}}